Schonfeld Strategic Advisors’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.08M | Sell |
16,228
-29,072
| -64% | -$3.73M | 0.01% | 886 |
|
|
2025
Q1 | $4.01M | Buy |
45,300
+32,100
| +243% | +$2.84M | 0.02% | 535 |
|
|
2024
Q4 | $1.15M | Sell |
13,200
-46,158
| -78% | -$4.03M | 0.01% | 996 |
|
|
2024
Q3 | $5.49M | Buy |
59,358
+55,408
| +1,403% | +$5.13M | 0.04% | 421 |
|
|
2024
Q2 | $426K | Buy |
+3,950
| New | +$426K | ﹤0.01% | 1426 |
|
|
2023
Q2 | – | Sell |
-69,629
| Closed | -$3.13M | – | 1999 |
|
|
2023
Q1 | $3.13M | Buy |
+69,629
| New | +$3.13M | 0.03% | 567 |
|
|
2022
Q4 | – | Sell |
-26,484
| Closed | -$1.74M | – | 2525 |
|
|
2022
Q3 | $1.74M | Buy |
+26,484
| New | +$1.74M | 0.01% | 930 |
|
|
2021
Q4 | – | Sell |
-19,818
| Closed | -$2.04M | – | 1990 |
|
|
2021
Q3 | $2.04M | Buy |
+19,818
| New | +$2.04M | 0.02% | 650 |
|
|
2021
Q1 | – | Sell |
-27,137
| Closed | -$3.04M | – | 1760 |
|
|
2020
Q4 | $3.04M | Buy |
27,137
+20,722
| +323% | +$2.32M | 0.04% | 483 |
|
|
2020
Q3 | $595K | Buy |
+6,415
| New | +$595K | 0.01% | 821 |
|
|
2020
Q1 | – | Sell |
-3,074
| Closed | -$246K | – | 1162 |
|
|
2019
Q4 | $246K | Sell |
3,074
-30,726
| -91% | -$2.46M | 0.01% | 1070 |
|
|
2019
Q3 | $2.48M | Sell |
33,800
-109,700
| -76% | -$8.06M | 0.07% | 272 |
|
|
2019
Q2 | $13.5M | Buy |
143,500
+21,500
| +18% | +$2.03M | 0.48% | 48 |
|
|
2019
Q1 | $9.77M | Buy |
+122,000
| New | +$9.77M | 0.34% | 71 |
|
|
2018
Q1 | – | Sell |
-13,588
| Closed | -$1.02M | – | 749 |
|
|
2017
Q4 | $1.02M | Buy |
+13,588
| New | +$1.02M | 0.08% | 303 |
|
|
2017
Q2 | – | Sell |
-17,849
| Closed | -$714K | – | 597 |
|
|
2017
Q1 | $714K | Buy |
+17,849
| New | +$714K | 0.07% | 311 |
|